chlorpheniramine has been researched along with Allergy, Peanut in 2 studies
Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The severity of nut allergy was graded (mild-severe) and emergency medication was allocated according to our criteria: all received oral antihistamines, injected adrenaline (EpiPen) was given to those with reactions with airway narrowing, milder reactions to low-dose exposure or concomitant asthma." | 1.33 | Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. ( Clark, AT; Ewan, PW, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loli-Ausejo, D | 1 |
| Vílchez-Sánchez, F | 1 |
| Gómez-Traseira, C | 1 |
| Tomás-Pérez, M | 1 |
| González-Muñoz, M | 1 |
| Ewan, PW | 1 |
| Clark, AT | 1 |
2 other studies available for chlorpheniramine and Allergy, Peanut
| Article | Year |
|---|---|
Fixed food eruption caused by peanut confirmed by open oral food challenge and in vitro cellular testing.
Topics: Adrenal Cortex Hormones; Arachis; Child, Preschool; Chlorpheniramine; Dermatitis; Eosinophil Cationi | 2020 |
Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Bertholletia; Bronchodilator Agents; C | 2005 |